α-
melanocyte stimulating hormone (α-
MSH) is an anti-inflammatory
peptide, proved to be beneficial in many
neuroinflammatory disorders acting through
melanocortin receptor 4 (MC4R). We previously determined that rat microglial cells express MC4R and that
NDP-MSH, an analog of α-
MSH, induces
PPAR-γ expression and
IL-10 release in these cells. Given the great importance of modulation of glial activation in
neuroinflammatory disorders, we tested the ability of
NDP-MSH to shape microglial phenotype and to modulate
Toll-like receptor (TLR)-mediated inflammatory responses. Primary rat cultured microglia were stimulated with
NDP-MSH followed by the TLR2 agonist Pam3CSK4 or the TLR4 agonist LPS.
NDP-MSH alone induced expression of the M2a/M2c marker Ag1 and reduced expression of the M2b marker Il-4rα and of the
LPS receptor Tlr4. Nuclear translocation of NF-κB subunits p65 and c-Rel was induced by LPS and these effects were partially prevented by
NDP-MSH.
NDP-MSH reduced LPS- and Pam3CSK4-induced TNF-α release but did not affect TLR-induced
IL-10 release. Also,
NDP-MSH inhibited TLR2-induced
HMGB1 translocation from nucleus to cytoplasm and TLR2-induced phagocytic activity. Our data show that
NDP-MSH inhibits TLR2- and TLR4-mediated proinflammatory mechanisms and promotes microglial M2-like polarization, supporting
melanocortins as useful tools for shaping microglial activation towards an alternative immunomodulatory phenotype.